Laurel Wealth Advisors (California)’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$205K	Sell	1,719 -209	-11%	-$24.9K	0.02%	632
2022 Q3	$205K	Sell	1,928 -166	-8%	-$17.7K	0.02%	609
2022 Q2	$204K	Sell	2,094 -702	-25%	-$68.4K	0.02%	636
2022 Q1	$262K	Sell	2,796 -64	-2%	-$6K	0.02%	630
2021 Q4	$244K	Buy	+2,860	New	+$244K	0.02%	690